Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...
Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...
"Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course ...
A new liquid biopsy method has the potential to monitor disease evolution in patients with prostate cancer. Data from the study, published in the Cancer Cell journal, showed that extracellular ...
Newswise — Prostate cancer (PCa) is a highly prevalent malignancy, heavily characterized by complex cellular heterogeneity and highly variable clinical outcomes. The Gleason score (GS) remains the ...
Prostate cancer remains one of the most common malignancies in men worldwide, ranking as the second most prevalent cancer and ...
Association of cardiovascular outcomes with GnRH agonist and antagonist therapy in non-metastatic prostate cancer. Addition of 18F-DCFPyL PSMA PET to MRI to avoid unnecessary biopsy in men on active ...
Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to ...
Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results